Robert Hettich: Decoding biological complexity with next-gen mass spectrometry
Scientists at the Department of Energy’s Oak Ridge National Laboratory recently welcomed Vanderbilt University colleagues for a symposium on basic science research, with a focus on potential collaborations in the biomedical and biotechnology spaces.
Daniel Jacobson, distinguished research scientist in the Biosciences Division at ORNL, has been elected a Fellow of the American Institute for Medical and Biological Engineering, or AIMBE, for his achievements in computational biology.
Troy Carter, director of the Fusion Energy Division at Oak Ridge National Laboratory, leads efforts to make fusion energy a reality, overseeing key projects like MPEX and fostering public-private collaborations in fusion research.
US ITER has completed delivery of all components for the support structure of the central solenoid, the 60-foot-tall superconducting magnet that is the “heart” of the ITER fusion machine.
Researchers at Georgia State University used the Summit supercomputer to study an elaborate molecular pathway called nucleotide excision repair. Decoding NER’s sophisticated sequence of events and the role of PInC in the pathway could provide key insights into developing novel treatments and preventing conditions that lead to premature aging and certain types of cancer.
During his first visit to Oak Ridge National Laboratory, Energy Secretary Chris Wright compared the urgency of the Lab’s World War II beginnings to today’s global race to lead in artificial intelligence, calling for a “Manhattan Project 2.”
Scientists designing the world’s first controlled nuclear fusion power plant, ITER, needed to solve the problem of runaway electrons, negatively charged particles in the soup of matter in the plasma within the tokamak, the magnetic bottle intended to contain the massive energy produced. Simulations performed on Summit, the 200-petaflop supercomputer at ORNL, could offer the first step toward a solution.
Ryan Culler is the program manager at Oak Ridge National Laboratory, where he oversees the production of actinium-225, a promising treatment for cancer. Driven by a personal connection to cancer through his late brother, Culler is dedicated to advancing medical isotopes to help improve cancer care.
Scientists conducted a groundbreaking study on the genetic data of over half a million U.S. veterans, using tools from the Oak Ridge National Laboratory to analyze 2,068 traits from the Million Veteran Program.
FREDA is a new tool being developed at ORNL that will accelerate the design and testing of next-generation fusion devices. It is the first tool of its kind to combine plasma and engineering modeling capabilities and utilize high performance computing resources.